Jazz Pharmaceuticals plc (JAZZ) is listed on NASDAQ in Pharmaceutical Stocks. It is $244.60, -2.59%, with a $15.9B market cap. RSI is 46.0, neutral. The latest reported quarter missed estimates. Insiders were net sellers across the listed trades.
Technical Analysis
RSI (14) 46.0 Neutral
Market Cap $15.9B
Volume 782.5K
Fundamentals — 10-Q Q2 2026
Revenue $2.3B
Net Income $485.9M
EPS $7.17
Operating Margin 25.7%
Net Margin 21.3%
Debt / Equity 0.9x
P/E Ratio 34.1x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Cozadd Bruce C | Director | Sell | 6,000 | $252.98 | $1.5M | 2026 Aug 3 |
| Cozadd Bruce C | Director | Sell | 6,000 | $240.47 | $1.4M | 2026 Jul 1 |
| Smith Mark Douglas | Director | Sell | 1,157 | $230.55 | $266,746 | 2026 Jun 15 |
| Cozadd Bruce C | Director | Sell | 6,000 | $235.12 | $1.4M | 2026 Jun 1 |
| Patil Neena M | EVP & Chief Legal Officer | Sell | 1,192 | $236.97 | $282,468 | 2026 May 28 |
| Pearce Samantha | EVP, Chief Commercial Officer | Sell | 6,907 | $235.41 | $1.6M | 2026 May 28 |
| Winningham Rick E | Director | Sell | 2,741 | $241.57 | $662,143 | 2026 May 22 |
| McSharry Heather Ann | Director | Sell | 2,000 | $241.00 | $482,000 | 2026 May 22 |
| Cozadd Bruce C | Director | Sell | 6,000 | $203.33 | $1.2M | 2026 May 1 |
| Cozadd Bruce C | Director | Sell | 6,000 | $190.50 | $1.1M | 2026 Apr 1 |
| Carr Patricia | SVP, Chief Accounting Officer | Sell | 1,287 | $182.94 | $235,444 | 2026 Mar 9 |
| Cozadd Bruce C | Director | Sell | 6,000 | $186.44 | $1.1M | 2026 Mar 3 |
| Riedel Norbert G | Director | Sell | 3,415 | $192.00 | $655,680 | 2026 Feb 27 |
| Carr Patricia | SVP, Chief Accounting Officer | Sell | 2,370 | $192.60 | $456,466 | 2026 Feb 27 |
| Patil Neena M | EVP & Chief Legal Officer | Sell | 55,600 | $191.56 | $10.7M | 2026 Feb 26 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 5,343 | $194.49 | $1.0M | 2026 Feb 26 |
| Henderson Mary Elizabeth | SVP, Technical Operations | Sell | 2,238 | $169.51 | $379,363 | 2025 Dec 9 |
| Carr Patricia | SVP, Chief Accounting Officer | Sell | 4,660 | $171.20 | $797,778 | 2025 Dec 5 |
| Cozadd Bruce C | Director | Sell | 77,500 | $177.81 | $13.8M | 2025 Nov 26 |
| McSharry Heather Ann | Director | Sell | 3,415 | $177.78 | $607,119 | 2025 Nov 20 |
Other Pharmaceutical Stocks
| Ticker | Price | RSI | Mkt Cap |
|---|---|---|---|
| | $1,173.34 | 46.3 | $1.1T |
| | $268.01 | 58.6 | $645.9B |
| | $148.31 | 64.1 | $365.9B |
| | $112.44 | 58.9 | $195.8B |
| | $255.53 | 48.7 | $451.6B |
| | $27.96 | 64.8 | $159.3B |
| | $794.08 | 58.2 | $82.1B |
| | $45.60 | 41.8 | -- |
Take JAZZ further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put JAZZ in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Jazz Pharmaceuticals plc next reports.
Set alerts on JAZZ
Get notified when Jazz Pharmaceuticals plc hits your price targets or technical conditions are met.
Get Started Free